Bausch Health Companies | VRX - Equity Capital And Reserves

Stock Price
7.32
Daily Change
0.01 0.07%
Monthly
0.90%
Yearly
3.47%
Q2 Forecast
7.29

Bausch Health Companies reported $-554M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Amgen USD 8.66B 961M Dec/2025
ANI Pharmaceuticals USD 540.72M 34.91M Dec/2025
Aurora Cannabis CAD 536.36M 30.74M Dec/2025
Bausch Health Companies USD -554M 910M Dec/2025
Biogen USD 18.21B 573.5M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Canopy Growth CAD 758.17M 22.16M Dec/2025
Corcept Therapeutics USD 647.8M 15.9M Dec/2025
Danaher USD 52.53B 1.46B Dec/2025
Drreddys Laboratories INR 4.14B 107.72M Dec/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
Nektar Therapeutics USD 89.83M 4.75M Dec/2025
Novo Nordisk DKK 194.05B 24.15B Dec/2025
Pacira USD 693.11M 34.1M Dec/2025
Perrigo USD 2.94B 1.51B Dec/2025
Phibro Animal Health USD 332.36M 20.68M Dec/2025
Prestige Brands USD 1.83B 4.48M Dec/2025
Supernus Pharmaceuticals USD 1.06B 12.05M Dec/2025
Vertex Pharmaceuticals USD 18.67B 1.35B Dec/2025
Zoetis USD 3.33B 2.07B Dec/2025